Xcout IntelCrossbow Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Crossbow Therapeutics, Inc. among biotech companies — ranked by similarity to what Crossbow Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Crossbow Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Crossbow Therapeutics, Inc.
Crossbow Therapeutics is a privately held biotechnology company founded in 2021 and headquartered in Cambridge, Massachusetts. The company develops potent antibody therapeutics aimed at expanding treatment options and combating cancer.
Crossbow Therapeutics, Inc. at a glance
Crossbow Therapeutics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series B, raised $77M in March 2026. Xcout tracks 10 named people at Crossbow Therapeutics, Inc., including Briggs Morrison (Chief Executive Officer). Xcout recorded 1 job posting from Crossbow Therapeutics, Inc. in the last 90 days.
Crossbow Therapeutics, Inc. leadership
- Briggs MorrisonChief Executive Officer
- Alexander NolteExecutive Officer
- Briggs MorrisonExecutive Officer
- Dmitri WiederschainExecutive Officer
- Alexandra CantleyDirector
- Alon LazarusDirector
4 more named people on record for Crossbow Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Crossbow Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $77M | 9 named | |
| SEC Form D filing | $30.3M | — | |
| SEC Form D filing | $37.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Crossbow Therapeutics, Inc.
Xcout recorded 1 job posting from Crossbow Therapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Crossbow Therapeutics, Inc.'s hiring signals →
Top 12 Crossbow Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Crossbow Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
HiFiBio Therapeutics is a clinical-stage immune modulation biotechnology company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel precision antibody therapeutics for immunology and oncology applications.
Similar biotech company
CrossBridge Bio, Inc. is a medical technology and biopharmaceutical company pioneering an approach to deliver the next generation of stable antibody-drug conjugates (ADCs).
Similar biotech company
Compass Therapeutics, Inc. is a biopharmaceutical firm focused on developing cancer treatments, with several therapeutic candidates currently in clinical trials. The company's work involves creating antibody-based medicines designed to address a variety of human health conditions. Among its leading clinical-stage programs are CTX-009, an experimental bispecific antibody engineered to inhibit the Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, both of which are crucial for the growth of new blood vessels and tumor vascularization. Another significant compound is CTX-471, an IgG4 monoclonal antibody that functions as an activator of CD137. Furthermore, their developmental pipeline features CTX-8371, a bispecific inhibitor that targets both PD-1 and PD-L1. The company was established in 2014 and operates from its headquarters in Boston, Massachusetts.
Biotechnology
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Health & Life Sciences
Matrisome Bio is a biotechnology startup headquartered in Cambridge, Massachusetts, focused on transforming cancer therapy by delivering potent payloads directly to the extracellular matrix of tumors and metastases.
Similar biotech company
Proximity Therapeutics, Inc. is a privately held biopharmaceutical and biotechnology company based in Cambridge, Massachusetts, founded in 2021. The neuro space company operates as a provider of biotechnology and develops next-generation medicines by controlling biological processes through proximity.
Biotechnology
Third Arc Bio, Inc. is a clinical-stage biotechnology company founded in 2022 and based in Ambler, Pennsylvania, dedicated to developing multifunctional antibodies optimized for best-in-class therapies.
Biotechnology
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotechnology
Ankyra Therapeutics is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. The company develops localized immune-mediated therapies for the treatment of cancer.
Biotechnology
Angiex Inc. is a private biotechnology company that focuses on novel biology to address the hallmarks of cancer lethality. The firm develops safe and effective cancer therapies and is located in Cambridge, Massachusetts.
Biotechnology
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Crossbow Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Crossbow Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →